BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 35740526)

  • 1. Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.
    Saxena S; Jena B; Gupta N; Das S; Sarmah D; Bhattacharya P; Nath T; Paul S; Fouda MM; Kalra M; Saba L; Pareek G; Suri JS
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology.
    Shui L; Ren H; Yang X; Li J; Chen Z; Yi C; Zhu H; Shui P
    Front Oncol; 2020; 10():570465. PubMed ID: 33575207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review).
    Trivizakis E; Papadakis GZ; Souglakos I; Papanikolaou N; Koumakis L; Spandidos DA; Tsatsakis A; Karantanas AH; Marias K
    Int J Oncol; 2020 Jul; 57(1):43-53. PubMed ID: 32467997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current role of machine learning and radiogenomics in precision neuro-oncology.
    Perillo T; de Giorgi M; Papace UM; Serino A; Cuocolo R; Manto A
    Explor Target Antitumor Ther; 2023; 4(4):545-555. PubMed ID: 37720347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework.
    Jena B; Saxena S; Nayak GK; Balestrieri A; Gupta N; Khanna NN; Laird JR; Kalra MK; Fouda MM; Saba L; Suri JS
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiogenomics in prostate cancer evaluation.
    Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
    Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning-Based Radiomics in Neuro-Oncology.
    Ehret F; Kaul D; Clusmann H; Delev D; Kernbach JM
    Acta Neurochir Suppl; 2022; 134():139-151. PubMed ID: 34862538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review.
    Feretzakis G; Juliebø-Jones P; Tsaturyan A; Sener TE; Verykios VS; Karapiperis D; Bellos T; Katsimperis S; Angelopoulos P; Varkarakis I; Skolarikos A; Somani B; Tzelves L
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine.
    Fathi Kazerooni A; Bagley SJ; Akbari H; Saxena S; Bagheri S; Guo J; Chawla S; Nabavizadeh A; Mohan S; Bakas S; Davatzikos C; Nasrallah MP
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of radiogenomics in genetically triggered thoracic aortic aneurysm and dissection: a narrative review.
    Lum RTW; Wang X; Zhang M; Zhang X; Ho JYK; Chow SCY; Fujikawa T; Wong RHL
    Ann Transl Med; 2023 Aug; 11(10):356. PubMed ID: 37675315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Applications of Artificial Intelligence in Neuro-Oncology.
    Rudie JD; Rauschecker AM; Bryan RN; Davatzikos C; Mohan S
    Radiology; 2019 Mar; 290(3):607-618. PubMed ID: 30667332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics and radiogenomics for precision radiotherapy.
    Wu J; Tha KK; Xing L; Li R
    J Radiat Res; 2018 Mar; 59(suppl_1):i25-i31. PubMed ID: 29385618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence-based risk stratification, accurate diagnosis and treatment prediction in gynecologic oncology.
    Jiang Y; Wang C; Zhou S
    Semin Cancer Biol; 2023 Nov; 96():82-99. PubMed ID: 37783319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence for nuclear medicine in oncology.
    Hirata K; Sugimori H; Fujima N; Toyonaga T; Kudo K
    Ann Nucl Med; 2022 Feb; 36(2):123-132. PubMed ID: 35028877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomics influence on the future of prostate cancer risk stratification.
    Banerjee V; Wang S; Drescher M; Russell R; Siddiqui MM
    Ther Adv Urol; 2022; 14():17562872221125317. PubMed ID: 36160762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI radiogenomics for intelligent diagnosis of breast tumors and accurate prediction of neoadjuvant chemotherapy responses-a review.
    Yin XX; Hadjiloucas S; Zhang Y; Tian Z
    Comput Methods Programs Biomed; 2022 Feb; 214():106510. PubMed ID: 34852935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence in cancer diagnostics and therapy: current perspectives.
    Majumder A; Sen D
    Indian J Cancer; 2021; 58(4):481-492. PubMed ID: 34975094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics and artificial intelligence for precision medicine in lung cancer treatment.
    Chen M; Copley SJ; Viola P; Lu H; Aboagye EO
    Semin Cancer Biol; 2023 Aug; 93():97-113. PubMed ID: 37211292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions.
    O'Sullivan NJ; Kelly ME
    Curr Oncol; 2023 May; 30(5):4936-4945. PubMed ID: 37232830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review.
    Lococo F; Ghaly G; Chiappetta M; Flamini S; Evangelista J; Bria E; Stefani A; Vita E; Martino A; Boldrini L; Sassorossi C; Campanella A; Margaritora S; Mohammed A
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.